WO2008028514A1 - Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate - Google Patents

Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate Download PDF

Info

Publication number
WO2008028514A1
WO2008028514A1 PCT/EP2006/065945 EP2006065945W WO2008028514A1 WO 2008028514 A1 WO2008028514 A1 WO 2008028514A1 EP 2006065945 W EP2006065945 W EP 2006065945W WO 2008028514 A1 WO2008028514 A1 WO 2008028514A1
Authority
WO
WIPO (PCT)
Prior art keywords
propionate
trimethylhydrazinium
ethanol
thmethylhydrazinium
salt
Prior art date
Application number
PCT/EP2006/065945
Other languages
French (fr)
Inventor
Jorge Silva
Original Assignee
Jorge Silva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2009525928A priority Critical patent/JP5214608B2/en
Application filed by Jorge Silva filed Critical Jorge Silva
Priority to EA200900408A priority patent/EA015037B1/en
Priority to EEP200900024A priority patent/EE05626B1/en
Priority to US12/310,385 priority patent/US8153842B2/en
Priority to CN2006800557521A priority patent/CN101541739B/en
Priority to GEAP200611172A priority patent/GEP20105079B/en
Priority to CA2661357A priority patent/CA2661357C/en
Priority to PCT/EP2006/065945 priority patent/WO2008028514A1/en
Priority to RS20140038A priority patent/RS53173B/en
Priority to EP06793164.2A priority patent/EP2069290B1/en
Priority to PL06793164T priority patent/PL2069290T3/en
Publication of WO2008028514A1 publication Critical patent/WO2008028514A1/en
Priority to LT2009008A priority patent/LT5598B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/26Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from organic compounds containing only halogen atoms as hetero-atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00Catalysts comprising molecular sieves
    • C07C2529/04Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • C07C2529/06Crystalline aluminosilicate zeolites; Isomorphous compounds thereof
    • C07C2529/40Crystalline aluminosilicate zeolites; Isomorphous compounds thereof of the pentasil type, e.g. types ZSM-5, ZSM-8 or ZSM-11

Definitions

  • the invention relates to a process for the preparation of pharmaceutically active compounds, namely to the pharmaceutically active substance 3-(2,2,2- trimethylhydrazinium)propionate dihydrate, the known medicine Meldonium (INN) of formula (1 ) )
  • Meldonium is a cardiovascular medicine with average daily dose 1.Og. Because this preparation is used as an over-the-counter drug, a need for an inexpensive large scale manufacturing process is needed. Known processes for the preparation of Meldonium are not convenient for large scale production.
  • the aim of this invention are improvements in the method for manufacturing Meldonium known hitherto allowing lower production costs and application for large scale manufacturing processes.
  • a number of processes for the preparation of compound of the formula (1 ) is known.
  • a common scheme is used hitherto to produce this compound: starting with 1 ,1-dimethylhydrazine and esters of acrylic acid 3-(2,2- dimethylhydrazino)propionic acid is prepared, which is alkylated by an appropriate alkylating agent (methyl chloride, methyl bromide, methyl iodide, dimethylsulphate etc.).
  • the halide or methylsulphate of alkyl-3-(2,2,2- trimethylhydrazinium)propionate thus obtained is subjected to hydrolysis and deionisation.
  • Known methods for the preparation of Meldonium differ by the approach to hydrolysis and/or deionisation of the corresponding 3-(2,2,2- thmethylhydrazinium)propionate salt.
  • alkyl-3-(2,2,2- thmethylhydrazinium)propionate salt is deionised by electrodialysis.
  • This process in production of Meldonium is applied in two different technical solutions (SU 1262900, RU 1262900, LV 5046 and Bacn ⁇ beB B.H., O ⁇ v ⁇ e ⁇ bHeH ⁇ o K).
  • H. TKaH M. H., FlyroBHH O. B., Ka ⁇ BMHbLU M.
  • the disadvantage of this process is a need for highly specialised equipment with enhanced requirements to the corrosion resistance of constructive materials used (platinum plated titanium electrodes, controlled diameter pore membrane, mechanical and chemical stability of membrane material, ceramic coated constructive elements of the electrodialysis equipment).
  • the main parameters of electrodialysis process have to be experimentally adapted - current, flow speed, concentration of solutions, distances between electrodes, form of the camera etc. Because of membrane pollution during the production process, the parameters initially set should be constantly changed. The membrane undergoes degradation during the process as well and has to be replaced regularly. Therefore the maintenance costs of such equipment are high and the scaling-up of the process is complicated. Simultaneously with dialysis electrolysis takes place and explosive gases are produced that cause safety problems. Therefore producing Meldonium using electrodialysis is also rather expensive.
  • solubilities of inorganic double salts were recently published (C.H.Yoder, J.P.Rowand, Application of the simple salt lattice energy approximation to the solubility of minerals. American Mineralogist, Volume 91 , pages 747-752, 2006).
  • the solubilities of the double salts are similar to the solubilities of the less soluble constituent salts or lie between the solubilities of the constituent salts. Therefore standard crystallization is not the method of choice for separation of the double salt constituents. It is known that double salts can be separated into their constituents by multiple fractional crystallizations at different temperatures. While such approach can be used for inorganic salts, it is not useful for medicines due to risk of decomposition of the labile organic component.
  • the present process can be conveniently used for conversion of alkyl-3- (2,2,2-trimethylhydrazinium)propionate chloride, bromide or methyl sulphate, as well as other easily hydrolysable ester of 3-(2,2,2- thmethylhydrazinium)propionate salt, for example - benzyl-3-(2,2,2- thmethylhydrazinium)propionate salt.
  • the amounts of alkaline agent can be used from equimolar ratio to more then double excess of the base, preferably 1 ,05-2,1 counted on 3-(2, 2, 2-trimethylhydrazinium)propionate ester salt.
  • esters of 3-(2,2,2-trimethylhydrazinium)propionate halide or methyl sulphate can be hydrolized under acidic conditions with catalysis by HCI, sulphuric acid, phosphoric acid etc., followed by neutralisation by an appropriate inorganic base (for example - sodium, potassium, calcium or magnesium hydroxide or another appropriate base, for example sodium, potassium, lithium or caesium carbonate or bicarbonate etc.) and the double salts thus obtained can be easily separated by the invented process using saturation of the solution with carbon dioxide or sulphur dioxide.
  • an appropriate inorganic base for example - sodium, potassium, calcium or magnesium hydroxide or another appropriate base, for example sodium, potassium, lithium or caesium carbonate or bicarbonate etc.
  • the invented method for producing 3-(2,2,2- thmethylhydrazinium)propionate dihydrate provides for the object of this invention - to develop a convenient and inexpensive large scale manufacturing process of the target compound, which differs from known processes by the separation of 3-(2,2,2-trimethylhydrazinium)propionate double salts using carbon dioxide or sulphur dioxide, which has a number of advantages over the known processes.
  • the novel method involves use of inexpensive and available reagents (sodium, potassium hydroxide or another appropriate base, carbon dioxide or sulphur dioxide, ethanol or propanol-2), easily available and common chemical technology equipment (reactors, vessels for crystallisation, centrifuges etc.). Said process is fast and gives high yields of high purity 3- (2,2,2-trimethylhydrazinium)propionate dihydrate or Meldonium (>99.5%) after simple crystallisation. Therefore the invented process enables to inexpensively produce high quality Meldonium.
  • the ethanol used in the following examples was commercial ethanol, containing approximately 95% by volume of ethanol and 5% of water.
  • Example 1 The ethanol used in the following examples, if not mentioned otherwise, was commercial ethanol, containing approximately 95% by volume of ethanol and 5% of water.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

A method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate by saponification of salts of 3-(2,2,2-trimethylhydrazinium)propionate esters with subsequent purification step using saturation with carbon dioxide or sulphur dioxide in alcoholic solution.

Description

Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
The invention relates to a process for the preparation of pharmaceutically active compounds, namely to the pharmaceutically active substance 3-(2,2,2- trimethylhydrazinium)propionate dihydrate, the known medicine Meldonium (INN) of formula (1 )
Figure imgf000002_0001
)
Meldonium is a cardiovascular medicine with average daily dose 1.Og. Because this preparation is used as an over-the-counter drug, a need for an inexpensive large scale manufacturing process is needed. Known processes for the preparation of Meldonium are not convenient for large scale production.
Therefore the aim of this invention are improvements in the method for manufacturing Meldonium known hitherto allowing lower production costs and application for large scale manufacturing processes.
A number of processes for the preparation of compound of the formula (1 ) is known. A common scheme is used hitherto to produce this compound: starting with 1 ,1-dimethylhydrazine and esters of acrylic acid 3-(2,2- dimethylhydrazino)propionic acid is prepared, which is alkylated by an appropriate alkylating agent (methyl chloride, methyl bromide, methyl iodide, dimethylsulphate etc.). The halide or methylsulphate of alkyl-3-(2,2,2- trimethylhydrazinium)propionate thus obtained is subjected to hydrolysis and deionisation. Known methods for the preparation of Meldonium differ by the approach to hydrolysis and/or deionisation of the corresponding 3-(2,2,2- thmethylhydrazinium)propionate salt.
Thus a method is known, according to which solution of halide or methylsulphate of alkyl- 3-(2,2,2-trimethylhydrazinium)propionate is treated with a strongly basic ion exchange resin, exchanging acid anion for hydroxyl anion, followed by spontaneous alkaline hydrolysis (USP. 4,481 ,218). The method has many disadvantages: strongly basic ion exchangers are unstable and undergo decomposition and oxidation during processing; they withstand only a limited number of regeneration cycles; large quantities or solvents, acids and bases as well as deionised water are needed to regenerate the resins; low ion exchange capacity and therefore high production costs of compound (1 ) by this process are typical. This process is not convenient for large scale production of Meldonium.
Some of disadvantages mentioned above are avoided if alkyl-3-(2,2,2- thmethylhydrazinium)propionate salt is deionised by electrodialysis. This process in production of Meldonium is applied in two different technical solutions (SU 1262900, RU 1262900, LV 5046 and BacnπbeB B.H., OιvιeπbHeHκo K). H., TKaH M. H., FlyroBHH O. B., KaπBMHbLU M. R. 3πeκτpoMeιvi6paHHbiM CMHτe3 3- (2,2,2-τpMMeτMπrMflpa3MHi/M)πpoπnoHaτa. >KypHaπ πpnκπaflH0M XMMMM, 1992, Bbiπ.12, TOM 65, CTp. 2823-2825).
The disadvantage of this process is a need for highly specialised equipment with enhanced requirements to the corrosion resistance of constructive materials used (platinum plated titanium electrodes, controlled diameter pore membrane, mechanical and chemical stability of membrane material, ceramic coated constructive elements of the electrodialysis equipment). The main parameters of electrodialysis process have to be experimentally adapted - current, flow speed, concentration of solutions, distances between electrodes, form of the camera etc. Because of membrane pollution during the production process, the parameters initially set should be constantly changed. The membrane undergoes degradation during the process as well and has to be replaced regularly. Therefore the maintenance costs of such equipment are high and the scaling-up of the process is complicated. Simultaneously with dialysis electrolysis takes place and explosive gases are produced that cause safety problems. Therefore producing Meldonium using electrodialysis is also rather expensive.
An alternative process of Meldonium production is known, according to which in the first step 1 ,1-dimethylhydrazine is condensed with acrylic acid trimethylsilyl ester and the resulting product is alkylated to halogenide of 3- (2,2,2-trimethylhydrazinium)propionate trimethylsilyl ester (RU 95118258.04). This approach is based on the well known fact that trimethylsilylesters of carboxylic acids undergo spontaneous hydrolysis in water even without alkaline catalysis. The main disadvantage of this process is considerably high costs of trimethylsilyl esters of acrylic acid compared with methyl acrylate.
A standard method of alkaline hydrolysis of carbonic acid esters in case of an alkyl-3-(2,2,2-trimethylhydrazinium)propionate salt could not be successfully realised till now because of the problems of separation of 3-(2,2,2- thmethylhydrazinium)propionate dihydrate and the resulting inorganic salts. It is known that 3-(2,2,2-trimethylhydrazinium)propionate forms various double salts (SU 849724, JloπbipeB B.A., floπrywHH F.B., BopoHKOB MT. FlpuKπaflHaa XMMMH 1 ,1 - flMMeτMπrnflpa3WHa v\ ero πpoM3BθflHbix. >KypHaπ πpnκπaflH0M XMMMM, 1998, Bbiπ.8, TOM 71 , CTp. 1233-1248). Some of them are very stable and can be used in agriculture as pesticides.
Our attempts to separate such double salts, for example double salt of NaCI and 3-(2,2,2-trimethylhydrazinium)propionate, present in the crude 3- (2,2,2-trimethylhydrazinium)propionate dihydrate obtained by hydrolysis of an alkyl-3-(2,2,2-trimethylhydrazinium)propionate chloride by simple dissolving or heating the product in alcohol were unsuccessful. As the result some of NaCI still remained in the product as the double salt and all attempts to prepare pure 3-(2,2,2-thmethylhydrazinium)propionate dihydrate (with content of the main substance >99,5%) failed. We have prepared pure 3-(2,2,2- thmethylhydrazinium)propionate double salt, for example, with NaI by treating ethyl 3-(2,2,2-trimethylhydrazinium)propionate iodide with sodium ethylate and established that it can be crystallized from ethanol without separation into constituents. Due to high solubility of 3-(2,2,2-thmethylhydrazinium)propionate dihydrate in water, this solvent also can not be used for separation of the inorganic salt constituent.
A summary of solubilities of inorganic double salts was recently published (C.H.Yoder, J.P.Rowand, Application of the simple salt lattice energy approximation to the solubility of minerals. American Mineralogist, Volume 91 , pages 747-752, 2006). The solubilities of the double salts are similar to the solubilities of the less soluble constituent salts or lie between the solubilities of the constituent salts. Therefore standard crystallization is not the method of choice for separation of the double salt constituents. It is known that double salts can be separated into their constituents by multiple fractional crystallizations at different temperatures. While such approach can be used for inorganic salts, it is not useful for medicines due to risk of decomposition of the labile organic component.
Surprisingly, we have now found that double salts of 3-(2,2,2- thmethylhydrazinium)propionate with the inorganic salts formed in the hydrolysis process can be completely separated, if the reaction solution in alcohol during precipitation of inorganic salts had been saturated with gaseous acid anhydride, namely carbon dioxide or sulphur dioxide. For example, the double salt of 3-(2,2,2-trimethylhydrazinium)propionate with KBr can thus be separated into its constituents and the inorganic salt can be completely removed from 3-(2,2,2-trimethylhydrazinium)propionate by a simple filtration. According to this approach 3-(2,2,2-thmethylhydrazinium)propionate dihydrate can be prepared and purified to pharmaceutical grade (>99,5%) by using conventional methods of purification (crystallisation).
The present process can be conveniently used for conversion of alkyl-3- (2,2,2-trimethylhydrazinium)propionate chloride, bromide or methyl sulphate, as well as other easily hydrolysable ester of 3-(2,2,2- thmethylhydrazinium)propionate salt, for example - benzyl-3-(2,2,2- thmethylhydrazinium)propionate salt. The amounts of alkaline agent can be used from equimolar ratio to more then double excess of the base, preferably 1 ,05-2,1 counted on 3-(2, 2, 2-trimethylhydrazinium)propionate ester salt.
This approach can be also used for conversion such intermediates as halide or methyl sulphate of 3-(2,2,2-trimethylhydrazinium)propionic acid. In this case esters of 3-(2,2,2-trimethylhydrazinium)propionate halide or methyl sulphate can be hydrolized under acidic conditions with catalysis by HCI, sulphuric acid, phosphoric acid etc., followed by neutralisation by an appropriate inorganic base (for example - sodium, potassium, calcium or magnesium hydroxide or another appropriate base, for example sodium, potassium, lithium or caesium carbonate or bicarbonate etc.) and the double salts thus obtained can be easily separated by the invented process using saturation of the solution with carbon dioxide or sulphur dioxide.
The invented method for producing 3-(2,2,2- thmethylhydrazinium)propionate dihydrate provides for the object of this invention - to develop a convenient and inexpensive large scale manufacturing process of the target compound, which differs from known processes by the separation of 3-(2,2,2-trimethylhydrazinium)propionate double salts using carbon dioxide or sulphur dioxide, which has a number of advantages over the known processes. Thus, the novel method involves use of inexpensive and available reagents (sodium, potassium hydroxide or another appropriate base, carbon dioxide or sulphur dioxide, ethanol or propanol-2), easily available and common chemical technology equipment (reactors, vessels for crystallisation, centrifuges etc.). Said process is fast and gives high yields of high purity 3- (2,2,2-trimethylhydrazinium)propionate dihydrate or Meldonium (>99.5%) after simple crystallisation. Therefore the invented process enables to inexpensively produce high quality Meldonium.
The examples below serve to illustrate the present invention. However, they are in no way to be regarded as limiting.
Examples
The ethanol used in the following examples, if not mentioned otherwise, was commercial ethanol, containing approximately 95% by volume of ethanol and 5% of water. Example 1
66.8 g of KOH (content of the main substance 90%) were suspended in 450 ml of ethanol and, at 18-2O 0C 120.5 g of methyl-3-(2,2,2- thmethylhydrazinium)propionate bromide were added during 5-10 min under stirring. The stirring was continued at 18-2O 0C until ester saponification was complete (controlled by TLC). The mixture was then cooled to 2-4 0C, and saturated with CO2 to pH 8.1-8.5. The precipitate thus formed was filtered off, washed with 3x20 ml of ethanol and the combined filtrates were evaporated. 89 g (92%) of semi-crystalline solid was obtained (3-(2,2,2- thmethylhydrazinium)propionate content 94%). Crystallization from ethanol or propanol-2 or another appropriate solvent gave 3-(2,2,2- thmethylhydrazinium)propionate dihydrate with m.p. 85-87 0C (purity >99.5%).
Example 2
34.0 g of KOH (content of the main substance 90%) were suspended in 450 ml of ethanol and at 18-2O 0C, 120.5 g of methyl-3-(2,2,2- trimethylhydrazinium)propionate bromide during 5-10 min were added under stirring. The stirring was continued at 18-2O 0C until ester saponification was complete (controlled by TLC). The mixture was then cooled to 2-4 0C, and saturated with CO2 to pH 8.1-8.5. The precipitate thus formed was filtered off, washed with 3x20 ml of ethanol and combined filtrates were evaporated. 90 g (93%) of semi-crystalline solid were obtained (3-(2,2,2- thmethylhydrazinium)propionate content 93%. Crystallization from ethanol or propanol-2 or another appropriate solvent gave 3-(2,2,2- thmethylhydrazinium)propionate dihydrate with m.p. 85-87 0C (purity >99.5%).
Example 3
66 g of KOH (content of the main substance 90%) were suspended in 450 ml of ethanol and, at 18-2O 0C, 136 g of methyl-3-(2,2,2- thmethylhydrazinium)propionate methylsulphate were added under stirring during 5-10 min. The stirring was continued at 18-2O 0C until the ester saponification was complete (controlled by TLC). The mixture was then cooled to 2-4 0C, saturated with CO2 to pH 8.1 - 8.5. Precipitate thus formed was filtered off, washed with 3x10 ml of ethanol and the combined filtrates were evaporated. 89.5 g (89%) of semi-crystalline solid was obtained. Crystallization from ethanol or propanol-2 or another appropriate solvent gave 3-(2,2,2- thmethylhydrazinium)propionate dihydrate with m.p. 85-870C (purity >99.5%).
Example 4
66 g of KOH (content of the main substance 90%) are suspended in 450 ml of ethanol and, at 18-2O 0C, 136 g of methyl-3-(2,2,2- thmethylhydrazinium)propionate methylsulphate were added under stirring during 5-10 min. The stirring was continued at 18-2O 0C until the ester saponification was complete (controlled by TLC). The mixture was then cooled to 2-4 0C, precipitate thus formed was filtered off and washed with 2x20 ml of ethanol. Filtrates were combined and saturated with CO2 to pH 8.1-8.5. Precipitate thus formed was filtered off, washed with 3x10 ml of ethanol and the combined filtrates were evaporated. 89.5 g (89%) of semi-crystalline solid were obtained (3-(2,2,2-trimethylhydrazinium)propionate content 91 %) and finally purified by electrodialysis. After evaporation the solid was crystallized from ethanol or propanol-2 or another appropriate solvent and gave 3-(2,2,2- trimethylhydrazinium)propionate dihydrate with m.p. 85-870C (purity >99.5%).
Example 5
24 g of NaOH were suspended in 450 ml of ethanol and, at 18-20 0C, 136 g of methyl-3-(2,2,2-trimethylhydrazinium)propionate chloride during 5-10 min were added under stirring. The stirring was continued at 18-20 0C until ester saponification was completed (controlled by TLC). The mixture was then cooled to 2-4 0C and saturated with CO2 to pH 8.1-8.5. Precipitate thus formed was filtered off, washed with 3x10 ml of ethanol and the combined filtrates were evaporated. 91 g (95%) of semi-crystalline solid were obtained (3-(2,2,2- thmethylhydrazinium)propionate content 95%). Crystallization from ethanol or propanol-2 or another appropriate solvent gave 3-(2,2,2- thmethylhydrazinium)propionate dihydrate with m.p. 85-870C (purity >99.5%).
Example 6
33 g of NaOH were suspended in 450 ml of ethanol and, at 18-20 0C, 92 g of methyl-3-(2,2,2-trimethylhydrazinium)propionate chloride during 5- 10 min were added under stirring. The stirring was continued at18-20 0C until ester saponification was completed (controlled by TLC). The mixture was then cooled to 2- 4 0C and saturated with CO2 to pH 8.1-8.5. Precipitate thus formed was filtered off, washed with 3x10 ml of ethanol and the combined filtrates were evaporated. 95 g (95%) of semi-crystalline solid were obtained (3-(2,2,2- thmethylhydrazinium)propionate content 95%). During crystallization from propanol-2 strongly basic ion exchange resin Amberlite IRA-400 is added in amount corresponding to 1.2 equivalents of Cl" remaining, after 5 min the resin is filtered off, washed with 20 ml of ethanol and the combined filtrates cooled. 3- (2,2,2-trimethylhydrazinium)propionate dihydrate with m.p. 85-870C. (purity >99.5%) is obtained.
Example 7
33 g of KOH (content of the main substance 90%) are suspended in 450 ml ethanol and, at 18-2O 0C, 113.5 g of methyl-3-(2,2,2- trimethylhydrazinium)propionate bromide were added under stirring during 5-10 min. The stirring was continued at 18-2O 0C until ester saponification was complete (controlled by TLC). The mixture was then cooled to 2-4 0C, inorganic precipitate thus formed was filtered off and washed with 2x20 ml of ethanol. Filtrates were combined and saturated with SO2 to pH 8.1-8.5. Precipitate formed was filtered off, washed with 3x10 ml of ethanol and the combined filtrates were evaporated. 90 g (93%) of semi-crystalline solid were obtained (3- (2,2,2-trimethylhydrazinium)propionate content 94%) and finally purified by electrodialysis. The solid obtained after evaporation was crystallized from ethanol or propanol-2 or another appropriate solvent and gave 3-(2,2,2- thmethylhydrazinium)propionate dihydrate with m.p. 85-870C (purity >99.5%).
Example 8
66 g of KOH (content of main substance 90%) were suspended in 450 ml of ethanol and, at 18-2O 0C, 136 g of methyl-3-(2,2,2- thmethylhydrazinium)propionate bromide were added under stirring during 5- 10 min. The stirring was continued at 18-2O 0C until ester saponification was completed (controlled by TLC). The mixture was then cooled to 2- 40C, inorganic precipitate thus formed was filtered off and washed with 2x20 ml of ethanol. Filtrates were combined and saturated with SO2 to pH 8.1-8.5. Precipitate thus formed is filtered off, washed with 3x10 ml ethanol and the combined filtrates were evaporated. 89 g (92%) of semi-crystalline solid were obtained (3-(2,2,2-trimethylhydrazinium)propionate content 94%). Crystallization from ethanol or propanol-2 or another appropriate solvent gave 3-(2,2,2- thmethylhydrazinium)propionate dihydrate with m.p. 85-870C (purity >99.5%).
Example 9
Ethyl 3-(2,2,2-thmethylhydraziniumpropionate iodide was refluxed with 2 equivalents of sodium ethylate in absolute ethanol for 20 hours, cooled, the precipitate filtered off, extracted with boiling methanol, the solution evaporated and the residue crystallized from absolute ethanol. Colourless crystals of the double salt of 3-(2,2,2-thmethylhydrazinium)propionate and sodium iodide were obtained, m.p. 186-1880C.

Claims

CLAIMS:
1. Process for preparing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate from salts of 3-(2,2,2-trimethylhydrazinium)propionate esters by saponification with an alkaline agent, followed by precipitation of inorganic salts by saturating the reaction mixture in organic solvent with gaseous acid anhydride and isolating the target compound by known methods.
2. Process of claim 1 wherein said salt is halide.
3. Process of claim 1 wherein said salt is methylsulphate.
4. Process of claim 1 wherein said ester is methylester.
5. Process of claim 1 wherein said ester is ethylester.
6. Process of claim 1 wherein said alkaline agent is selected from the group, consisting of sodium, potassium, lithium, caesium, calcium and magnesium oxides, hydroxides, carbonates and bicarbonates.
7. Process of claim 1 wherein said alkaline agent is used in molar ratio 1.05- 2.15 to said salt.
8. Process of claim 1 wherein said alkaline agent is potassium hydroxide.
9. Process of claim 1 wherein said alkaline agent is sodium hydroxide.
10. Process of claim 1 wherein said organic solvent is selected from the group, consisting of methanol, ethanol and propanol-2.
11. Process of claim 1 wherein said acid anhydride is carbon dioxide.
12. Process of claim 1 wherein said acid anhydride is sulphur dioxide.
PCT/EP2006/065945 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate WO2008028514A1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GEAP200611172A GEP20105079B (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium) propionate dihydrate
EA200900408A EA015037B1 (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
EEP200900024A EE05626B1 (en) 2006-09-04 2006-09-04 Method for the preparation of 3- (2,2,2-trimeth-lh drasinium) propionate dihydrate
US12/310,385 US8153842B2 (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethyl-hydrazinium) propionate dihydrate
CN2006800557521A CN101541739B (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
JP2009525928A JP5214608B2 (en) 2006-09-04 2006-09-04 Method for producing 3- (2,2,2-trimethylhydrazinium) propionate dihydrate
CA2661357A CA2661357C (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
EP06793164.2A EP2069290B1 (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
RS20140038A RS53173B (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
PCT/EP2006/065945 WO2008028514A1 (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
PL06793164T PL2069290T3 (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
LT2009008A LT5598B (en) 2006-09-04 2009-02-13 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2006/065945 WO2008028514A1 (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate

Publications (1)

Publication Number Publication Date
WO2008028514A1 true WO2008028514A1 (en) 2008-03-13

Family

ID=38051748

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/065945 WO2008028514A1 (en) 2006-09-04 2006-09-04 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate

Country Status (12)

Country Link
US (1) US8153842B2 (en)
EP (1) EP2069290B1 (en)
JP (1) JP5214608B2 (en)
CN (1) CN101541739B (en)
CA (1) CA2661357C (en)
EA (1) EA015037B1 (en)
EE (1) EE05626B1 (en)
GE (1) GEP20105079B (en)
LT (1) LT5598B (en)
PL (1) PL2069290T3 (en)
RS (1) RS53173B (en)
WO (1) WO2008028514A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2128126A1 (en) 2008-05-26 2009-12-02 Grindeks, a joint stock company New process for the preparation of 3-(2,2,2-Trimethylhydrazinium) propionate dihydrate
WO2009144225A1 (en) * 2008-05-26 2009-12-03 Grindeks, A Joint Stock Company New process for the preparation of 3-(2,2,2- trimethylhydrazinium) propionate dihydrate
RU2559314C1 (en) * 2014-07-14 2015-08-10 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
US9953352B2 (en) 2009-09-10 2018-04-24 Visa International Service Association Third party merchant-funded rewards accrual and redemption network
RU2806361C1 (en) * 2023-04-05 2023-10-31 Игорь Андреевич Сорокин Method of producing 3-(2,2,2-trimethylhydrazinium)propionate

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102093254B (en) * 2010-11-19 2013-08-14 绍兴文理学院 Preparation method of 3-(2,2,2-trimethylhydrazine)propionate dihydrate
CN101973909B (en) * 2010-11-19 2013-03-06 绍兴文理学院 Preparation method of mildronate
RU2485953C1 (en) * 2012-04-12 2013-06-27 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Complex of 3-(2,2,2-trimethylhydrazinium)propionate-2-ethyl-6-methyl-3-hydroxypyridinium disuccinate possessing antihypoxic and adaptogenic action, and method for preparing it
CN104151191A (en) * 2014-01-23 2014-11-19 阿拉法特.阿依别克 Novel method for synthesizing mildronate medical raw material
CN104151192A (en) * 2014-05-07 2014-11-19 东力(南通)化工有限公司 Improved method of preparation technology of mildronate intermediate 3-(2,2,2-trimethylhydrazine) methyl acrylate methyl sulfate
CN104163776A (en) * 2014-05-28 2014-11-26 东力(南通)化工有限公司 Method for improving preparation technology of 3-(2,2-dimethylhydrazino)methyl propionate and 3-(2,2,2-trimethylhydrazino)methyl propionate
CN109369447B (en) * 2018-11-05 2022-05-13 东力(南通)化工有限公司 Improved method of preparation technology of 3- (2, 2, 2-trimethylhydrazinium) propionate dihydrate
CN111333534B (en) * 2019-12-13 2022-06-28 东力(南通)化工有限公司 Method for preparing 3- (2, 2, 2-trimethylhydrazinium) propionate dihydrate by methylating methyl halide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481218A (en) 1978-11-27 1984-11-06 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr 3-(2,2,2-Trimethylhydrazinium)propionate and method for the preparation and use thereof
LV5046A3 (en) 1992-12-18 1993-06-10 Univ Rigas Tehniska The yield of 3- (2,2,2-trimethylhydrazinium) propionate dihydrate
RU95118258A (en) 1995-10-26 1997-09-20 Иркутский институт органической химии СО РАН METHOD FOR OBTAINING DIHYDRATE OF 3- (2,2,2-TRIMETHYL-HYDRAZINE) PROPIONATE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2259726A (en) * 1939-11-16 1941-10-21 Hercules Powder Co Ltd Method of producing refined, noncrystallizable rosin
JPS5220993B2 (en) * 1971-10-27 1977-06-07
GR62859B (en) * 1976-10-12 1979-06-30 Procter & Gamble Soap making
DE2923773A1 (en) * 1979-06-12 1980-12-18 Bayer Ag METHOD FOR PRODUCING TRANS-3,3-DIMETHYL-CYCLOPROPAN-1,2-DICARBONIC ACID
JPH0291049A (en) * 1988-09-21 1990-03-30 Lonza Ag Production of gamma-butyrobetaine
RU2114822C1 (en) 1995-10-26 1998-07-10 Иркутский институт органической химии СО РАН Method for production of dihydrate of 3-(2,2,2-trimethyl hydrazinium)propionate
JP3620243B2 (en) * 1996-10-31 2005-02-16 住友化学株式会社 Method for producing methionine
WO2001016066A2 (en) * 1999-08-30 2001-03-08 Mossi & Ghisolfi Overseas S.A. Closely linking a nda process with a pen process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481218A (en) 1978-11-27 1984-11-06 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr 3-(2,2,2-Trimethylhydrazinium)propionate and method for the preparation and use thereof
LV5046A3 (en) 1992-12-18 1993-06-10 Univ Rigas Tehniska The yield of 3- (2,2,2-trimethylhydrazinium) propionate dihydrate
RU95118258A (en) 1995-10-26 1997-09-20 Иркутский институт органической химии СО РАН METHOD FOR OBTAINING DIHYDRATE OF 3- (2,2,2-TRIMETHYL-HYDRAZINE) PROPIONATE

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C.H.YODER; J.P.ROWAND: "Application of the simple salt lattice energy approximation to the solubility of minerals", AMERICAN MINERALOGIST, vol. 91, 2006, pages 747 - 752
LOPYREV V.A.; DOLGUSHIN G.V.; VORONKOV M.G.: "Applied : Chemistry of 1,1-;dimethylhydrazine and its derivatives", JOURNAL OF APPLIED CHEMISTRY (RUS, vol. 71, no. 8, 1998, pages 1233 - 1248
VASILYEV V.N.; OMELCHENKO Y.N.; TKACH I.N.; PUGOVICS O.V.; KALVINS LJ.: "Electromembrane synthesis of 3-(2,2,2-trimethylhydrazinium)propionate", JOURNAL OF APPLIED CHEMISTRY (RUS, vol. 65, no. 12, 1992, pages 2823 - 2825

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2128126A1 (en) 2008-05-26 2009-12-02 Grindeks, a joint stock company New process for the preparation of 3-(2,2,2-Trimethylhydrazinium) propionate dihydrate
WO2009144225A1 (en) * 2008-05-26 2009-12-03 Grindeks, A Joint Stock Company New process for the preparation of 3-(2,2,2- trimethylhydrazinium) propionate dihydrate
CN102036950A (en) * 2008-05-26 2011-04-27 格林代克斯联合股份公司 New process for the preparation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate
EA016876B1 (en) * 2008-05-26 2012-08-30 Гриндекс, Джоинт Сток Кампани New process for the preparation of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
CN102036950B (en) * 2008-05-26 2013-10-09 格林代克斯联合股份公司 New process for the preparation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate
US9953352B2 (en) 2009-09-10 2018-04-24 Visa International Service Association Third party merchant-funded rewards accrual and redemption network
US10552883B2 (en) 2009-09-10 2020-02-04 Visa International Service Association Third party merchant-funded rewards accrual and redemption network
RU2559314C1 (en) * 2014-07-14 2015-08-10 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
RU2806361C1 (en) * 2023-04-05 2023-10-31 Игорь Андреевич Сорокин Method of producing 3-(2,2,2-trimethylhydrazinium)propionate

Also Published As

Publication number Publication date
LT2009008A (en) 2009-07-27
LT5598B (en) 2009-10-26
EE05626B1 (en) 2013-02-15
EP2069290B1 (en) 2013-11-13
JP5214608B2 (en) 2013-06-19
CA2661357A1 (en) 2008-03-13
GEP20105079B (en) 2010-09-10
EE200900024A (en) 2009-06-15
US20090318731A1 (en) 2009-12-24
CN101541739A (en) 2009-09-23
PL2069290T3 (en) 2014-04-30
US8153842B2 (en) 2012-04-10
CA2661357C (en) 2013-08-13
EP2069290A1 (en) 2009-06-17
EA015037B1 (en) 2011-04-29
RS53173B (en) 2014-06-30
EA200900408A1 (en) 2009-08-28
CN101541739B (en) 2012-06-27
JP2010502577A (en) 2010-01-28

Similar Documents

Publication Publication Date Title
EP2069290B1 (en) Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
TW505627B (en) Method for preparing purified terephthalic acid
JP5214615B2 (en) Process for preparing halogenated N-alkylnaltrexone
JP2006503021A (en) Method and apparatus for producing formate formate and use thereof
JP2009525326A (en) Method for producing high-purity monopentaerythritol and monopentaerythritol produced by the method
BRPI0708623B1 (en) method for preparing an organic amine / lactic acid complex
CN101993447A (en) Method for synthesizing Prasugrel artificially
JPH0674243B2 (en) Optically active atenolol salt with high optical purity and process for producing atenolol
CN111909088A (en) Utilizing BTC/Ph3Method for preparing isoquinoline hydrochloride intermediate and Rho kinase inhibitor by PO chloro system
CN108383745B (en) Preparation method of aceclofenac
JP7483305B2 (en) Recovery step of 3-hydroxypropionate crystals and 3-hydroxypropionic acid
CN109369447B (en) Improved method of preparation technology of 3- (2, 2, 2-trimethylhydrazinium) propionate dihydrate
WO2012070066A1 (en) Process for the preparation of taurolidine and its intermediates thereof
US8431739B2 (en) Process for the preparation of gabapentin
CN107311990A (en) A kind of preparation method of olmesartan medoxomil
CN113968841B (en) Preparation method of fasudil hydrochloride hemihydrate
JP7233114B2 (en) Efficient crystallization process for preparing ultrapure treprostinil and crystals prepared therefrom
CN111333534B (en) Method for preparing 3- (2, 2, 2-trimethylhydrazinium) propionate dihydrate by methylating methyl halide
WO2005121061A1 (en) Novel process for producing ibuprofen sodium dihydrate
JP2001316353A (en) Method for producing perfluoroalkanesulfinic acid salt
JP2001526291A (en) Method for purifying solution of ampicillin prodrug ester
CN115819216A (en) Preparation method of 10-hydroxy-2-decenoic acid
KR102096924B1 (en) Draw solution for forward osmosis using salt of polyvalent carboxylic acid and use thereof
JP2006036699A (en) alpha-HYDROXYCARBOXYLIC ACID ALUMINUM SALT, ITS COMPLEX SALT AND METHOD FOR PRODUCING THE SAME
CN101066936B (en) Refining process of ethyl dihydrazone

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680055752.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06793164

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: LT2009008

Country of ref document: LT

WWE Wipo information: entry into national phase

Ref document number: 12310385

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2661357

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009525928

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1001/KOLNP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 11172

Country of ref document: GE

WWE Wipo information: entry into national phase

Ref document number: 2006793164

Country of ref document: EP

Ref document number: 200900408

Country of ref document: EA

ENP Entry into the national phase

Ref document number: 2009008

Country of ref document: LT

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: P-2014/0038

Country of ref document: RS